680 filings
Page 10 of 34
6-K
qm9m062e46
28 Jan 21
Current report (foreign)
7:31am
6-K
k1ds378639rphdu3pz
14 Jan 21
Current report (foreign)
2:28pm
6-K
odm5wbvx s7s
14 Jan 21
Amended and Restated Underwriting Agreement
9:21am
6-K
djy3deu212 9ue
11 Jan 21
Current report (foreign)
4:45pm
6-K
apjecqyl i3hqew
11 Jan 21
RedHill’s Partner Cosmo Pharmaceuticals Successfully
7:00am
6-K
9fvfbrasge2a o25f0q
6 Jan 21
RedHill Biopharma's RHB-204 Granted FDA Fast Track
7:00am
6-K
638v323 4xm
31 Dec 20
RedHill Biopharma Announces Positive Top-Line Safety and Efficacy Data from Phase 2 COVID-19 Study of Opaganib
9:30am
6-K
4tagllpwczv4xs2gy
22 Dec 20
Current report (foreign)
7:00am
6-K
qwoe980rg 1rfq
15 Dec 20
Current report (foreign)
9:30am
6-K
9y6o1t s3xuizg76
14 Dec 20
Current report (foreign)
8:00am
6-K
kcv2oy
7 Dec 20
Current report (foreign)
7:00am
6-K
psdimx83 s65o
25 Nov 20
Current report (foreign)
10:42am
6-K
tk8byj
23 Nov 20
RedHill Biopharma to Present at Evercore ISI
8:00am
6-K
jz0p2cjhu7zdr3
20 Nov 20
Current report (foreign)
8:00am
6-K
87z2dq6ikihjh
19 Nov 20
RedHill Announces Unanimous DSMB Recommendation to
7:00am
6-K
m3c f35kc
17 Nov 20
Current report (foreign)
7:00am
6-K
k2ksl rep5
16 Nov 20
Phase 2 Study with Opaganib – Data Expected in the Coming
10:00am
6-K
q4w3i7r9dfo
13 Nov 20
Current report (foreign)
7:00am
6-K
fgy6n2clvbdk7xokwd
12 Nov 20
Current report (foreign)
7:00am
6-K
qsfkn in8ygomj20
5 Nov 20
Current report (foreign)
7:00am